Evidence map›Paper›PMID 27052221›Full record

ReviewWiener klinische Wochenschrift2016

[Insulin therapy of diabetes].

Monika Lechleitner, Michael Roden, Raimund Weitgasser, Bernhard Ludvik, Peter Fasching, Friedrich Hoppichler, Alexandra Kautzky-Willer, Guntram Schernthaner, Rudolf Prager, Thomas C Wascher

Abstract readReview
PubMed Publisher
In one paragraph

Review in Wiener klinische Wochenschrift, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monika LechleitnerInterne Abteilung, Landeskrankenhaus Hochzirl - Natters, Hochzirl, Österreich. monika.lechleitner@tirol-kliniken.at.
Michael RodenInstitut für Klinische Diabetologie, Deutsches Diabetes-Zentrum DDZ, Düsseldorf, Deutschland.
Raimund WeitgasserAbteilung für Innere Medizin, Privatklinik Wehrle-Diakonissen, Salzburg, Österreich.
Bernhard LudvikKlinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Peter Fasching5. Medizinische Abteilung mit Rheumatologie, Stoffwechselerkrankungen und Rehabilitation, Wilhelminenspital der Stadt Wien, Wien, Österreich.
Friedrich HoppichlerInterne Abteilung, Krankenhaus der Barmherzigen Brüder Salzburg, Salzburg, Österreich.
Alexandra Kautzky-WillerKlinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich.
Guntram Schernthaner1. Medizinische Abteilung, Krankenanstalt Rudolfstiftung der Stadt Wien, Wien, Österreich.
Rudolf Prager3. Medizinische Abteilung, Krankenhaus Hietzing der Stadt Wien und Karl Landsteiner Institut für Stoffwechselerkrankungen und Nephrologie, Wien, Österreich.
Thomas C Wascher1. Medizinische Abteilung, Hanuschkrankenhaus, Wien, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperglycemia contributes to morbidity and mortality in patients with diabetes. Thus, reaching treatment targets with regard to control of glycemia is a central goal in the therapy of diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the practical use of insulin according to current scientific evidence and clinical studies.

Indexed as

Practice Guidelines as TopicAustriaDiabetes Mellitus, Type 2Dose-Response Relationship, DrugDrug Administration ScheduleEvidence-Based MedicineHumansHyperglycemiaHypoglycemic AgentsInsulinTreatment OutcomeHypoglycemic AgentsInsulinDosageInsulin therapyRegimen

Identifiers

PMID27052221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.